Provexis plc (LON:PXS)
1.25p+11.11%
Spriggl Score: Weak— sign in to explore; full breakdown with Premium
Last 30 trading days
Spriggl AI Verdict
“Valuation hinges on stalled Chinese approval; royalty cuts help but cash runway remains dangerously tight.”
Sign up free to read the full investment thesis, bull case, bear case and what to watch.
About Provexis plc
Provexis plc, together with its subsidiaries, develops, licenses, and sells functional foods, medical foods, and dietary supplements worldwide. The company offers syrup and powder versions of Fruitflow, a tomato extract that reduces the propensity for aberrant blood clotting typi…
- Sector:
- Healthcare
- Industry:
- Drug Manufacturers - Specialty & Generic
- Market Cap:
- £25.5M
Recent dividends
No recent dividends recorded.
Get the full Spriggl analysis — free
A free Spriggl account gets you the screener, a watchlist, AI verdicts and a free full report every day — across Provexis plc and 1,500+ UK and US stocks. The full score breakdown and AI analysis come with Premium.
Start free